Inadequate Attempts to Measure the Microheterogeneity of Transthyretin by Low-Resolution Mass Spectrometry (Letters) (Letter to the Editor)
Clinical Chemistry 2005, July, 51, 7
-
- $5.99
-
- $5.99
Publisher Description
To the Editor: Recently, the authors of 2 studies have claimed to measure accurately the microheterogeneity of transthyretin (TTR) variants by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) immunoassays (1, 2). Here we report that the mass spectrometric performance in those studies was not adequate to measure the respective TTR variants.
GENRE
Science & Nature
RELEASED
2005
July 1
LANGUAGE
EN
English
LENGTH
8
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
235.9
KB
Selected Reaction Monitoring Mass Spectrometry (SRM-MS) in Proteomics
2020
Proteome Characterization and Proteomics
2003
Proteomic and Metabolomic Approaches to Biomarker Discovery
2019
Protein Analysis using Mass Spectrometry
2017
Separation Techniques Applied to Omics Sciences
2021
Applications of MALDI-TOF Spectroscopy
2014
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998